Voyager Therapeutics, Inc.
VYGR
$3.47
-$0.06-1.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.51% | 36.54% | 36.03% | 46.19% | 94.26% |
| Total Receivables | -94.68% | 504.61% | -2.96% | -86.35% | 13,116.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.49% | 46.71% | 20.03% | 53.45% | -12.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 38.94% | -- | -- | -- | -13.18% |
| Total Current Assets | -13.41% | 42.58% | 35.22% | 35.20% | 156.78% |
|
|
|||||
| Total Current Assets | -13.41% | 42.58% | 35.22% | 35.20% | 156.78% |
| Net Property, Plant & Equipment | 58.86% | 59.70% | 63.00% | 75.98% | -10.01% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 80.41% | 80.41% | 80.41% | 90.76% | 5.15% |
| Total Assets | 11.89% | 44.59% | 38.25% | 39.64% | 120.44% |
|
|
|||||
| Total Accounts Payable | 149.13% | -3.36% | 57.02% | 104.95% | -37.49% |
| Total Accrued Expenses | -15.76% | 3.54% | 13.39% | -0.58% | 115.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 125.84% | 124.69% | 123.56% | 103.29% | 12.99% |
| Total Finance Division Other Current Liabilities | -43.11% | -48.87% | -35.21% | 805.62% | -27.78% |
| Total Other Current Liabilities | -43.11% | -48.87% | -35.21% | 805.62% | -27.78% |
| Total Current Liabilities | -22.82% | -28.33% | -11.60% | 263.87% | -11.13% |
|
|
|||||
| Total Current Liabilities | -22.82% | -28.33% | -11.60% | 263.87% | -11.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 113.52% | 114.12% | 114.67% | 115.13% | -15.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -79.01% | -66.12% | -60.92% | -82.27% | 347.71% |
| Total Liabilities | -18.85% | -19.17% | -13.48% | 7.85% | 14.58% |
|
|
|||||
| Common Stock & APIC | 25.89% | 25.91% | 26.03% | 26.17% | 9.89% |
| Retained Earnings | -24.89% | 8.15% | 3.09% | -1.13% | 33.63% |
| Treasury Stock & Other | -747.92% | 86.69% | -292.48% | -283.33% | 78.08% |
| Total Common Equity | 26.84% | 87.44% | 68.53% | 57.12% | 300.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.84% | 87.44% | 68.53% | 57.12% | 300.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.84% | 87.44% | 68.53% | 57.12% | 300.41% |
|
|
|||||